HoneyFil Reviews 2026: HoneyFil Publishes Dose Comparison Showing How Its Label Amounts Measure Against Published Research

Company sets four disclosed ingredient amounts beside the daily doses used in clinical studies and reports that only one falls within the studied range

AURORA, CO, November 5, 2026 – HoneyFil, the maker of a once-daily gummy dietary supplement for adult men, today published a dose comparison that sets the four ingredient amounts printed on its label beside the daily doses used in published research. The comparison finds that its tongkat ali amount, 200 mg, matches the low end of the range used in clinical trials, while its ashwagandha, maca and L-arginine amounts fall well below the studied doses.

The company said it released the comparison because a printed milligram figure is only useful to a buyer when it can be checked against the research, and because most multi-ingredient supplement labels do not make that check possible. HoneyFil prints individual amounts for four of its six active ingredients rather than grouping all six under a single proprietary blend weight.

“Printing an amount on the label is only half of transparency. The other half is showing people how that amount compares with what researchers actually tested, even when the answer is not flattering,” said Kevin Show, Product Lead at HoneyFil. “Our tongkat ali figure lines up with the published trials. Our other amounts do not, and we think buyers should hear that from us directly before they read it anywhere else.”

Official Website: honeyfil.store

Key Findings of the Dose Comparison

The comparison reports four main findings:

Tongkat ali, at 200 mg, matches the low end of the 200 to 400 mg daily range used in published trials, although the label does not state a standardisation figure.

Ashwagandha, at 100 mg, is about one third of the lowest daily amount in the range cited by the NIH Office of Dietary Supplements.

Maca, at 100 mg, is between one fifteenth and one thirty-fifth of the daily doses used in clinical trials.

L-arginine, at 50 mg, is about one thirtieth of the lowest daily dose used in human studies.

The company also confirmed that no published clinical trial has tested HoneyFil as a finished product.

Why Label Format Matters

How a supplement label is written carries regulatory weight. Under 21 CFR 101.36, U.S. supplement makers may group ingredients into a proprietary blend and declare only the blend’s total weight, without stating how much of each component it contains. The practice is legal and common, and it is the main reason many supplement labels cannot be compared with published research.

HoneyFil uses the blend option for two of its six ingredients and does not use it for the other four. The four ingredients with stated amounts are tongkat ali extract (Eurycoma longifolia) at 200 mg, maca root extract at 100 mg, ashwagandha extract at 100 mg and L-arginine HCl at 50 mg. The two ingredients listed without amounts are Epimedium sagittatum extract and a combined beet root and grape seed extract. The published listing does not give an extraction ratio or a standardisation percentage for any of the six.

The serving is one gummy per day. The brand describes HoneyFil as gluten-free and non-GMO and states that it is made in the United States in a GMP-certified, FDA-registered facility. FDA registration of a facility is an administrative filing requirement. It is not FDA approval of the product, and it does not mean the agency has reviewed any claim about the product.

How the Comparison Was Built

The comparison covers only the four ingredients that carry stated amounts. For each one, it sets the label figure beside the daily doses used in a published randomized trial, systematic review or federal reference source. The two ingredients without stated amounts could not be reviewed this way. The company said leaving them out reflects the missing numbers rather than a judgement about the ingredients themselves.

The comparison reports each study’s findings as the authors stated them, including results that were mixed or did not reach statistical significance.

Tongkat Ali Extract (Eurycoma Longifolia), 200 mg

Tongkat ali is a root extract with a long history of traditional use across Southeast Asia, and it is the most thoroughly trialled ingredient in the formula.

In a double-blind, placebo-controlled study published in the Journal of the International Society of Sports Nutrition (Talbott, S.M., et al., 2013, 10:28), 63 moderately stressed adults took 200 mg a day of a standardised root extract for four weeks. The researchers reported salivary cortisol about 16 percent lower, along with better scores for tension, anger and confusion on a standard mood questionnaire.

A systematic review and meta-analysis in Medicina (Leisegang, K., et al., 2022, 58(8):1047) combined five randomized trials of tongkat ali in men and examined hormone-related outcomes. The authors found the clearest effects in older men and in men with low starting hormone levels, and smaller, less consistent effects in younger men whose starting levels were in the normal range.

Clinical protocols for tongkat ali generally fall between 200 and 400 mg a day. HoneyFil’s 200 mg sits at the lower edge of that range, not below it. Because the label does not state a standardisation figure, the comparison notes that it is not possible to confirm whether the active compound content matches the extracts used in these studies.

Ashwagandha Extract, 100 mg

Ashwagandha is an adaptogenic herb studied mainly for stress-related outcomes. A systematic review and meta-analysis in Nutrition and Health (Albalawi, A.A., 2025, 31(4):1395-1408), covering 488 participants, reported an average cortisol reduction of 1.16 µg/dL. The same analysis found no significant pooled improvement in perceived stress.

The NIH Office of Dietary Supplements cites a provisional expert recommendation of 300 to 600 mg a day of standardised root extract in its Ashwagandha fact sheet. HoneyFil’s 100 mg is roughly one third of the lowest figure in that range.

Maca Root Extract, 100 mg

Maca is a Peruvian root crop with a long record of traditional use as a food. A systematic review in BMC Complementary and Alternative Medicine (Shin, B.C., et al., 2010, 10:44) identified four randomized trials with 131 participants in total, using daily doses of 1.5 to 3.5 grams. The reviewers concluded that the evidence was not strong enough to support firm conclusions.

The 100 mg in HoneyFil is between one fifteenth and one thirty-fifth of the doses used in those trials.

L-Arginine HCl, 50 mg

L-arginine is an amino acid the body uses to make nitric oxide, which plays a role in blood vessel function. A meta-analysis in the American Journal of Clinical Nutrition (Bai, Y., et al., 2009, 89(1):77-84) reported improved flow-mediated dilation after short-term oral L-arginine, but only in participants whose starting values were low.

Human studies of L-arginine measure doses in grams rather than milligrams, usually 1.5 to 5 grams a day. HoneyFil’s 50 mg is about one thirtieth of the lowest end of that range.

What the Disclosed Amounts Show

The published findings are also mixed. The ashwagandha meta-analysis found a cortisol reduction but no significant pooled improvement in perceived stress. The maca review judged its evidence too limited for firm conclusions. The L-arginine meta-analysis found an effect only in people with low baseline values. The tongkat ali meta-analysis saw its clearest effects in older men and men with low starting levels rather than in the general adult population.

In practical terms, the comparison describes HoneyFil as a tongkat ali product with smaller supporting amounts of the other ingredients. A buyer whose main interest is tongkat ali will find a label figure that lines up with the research. A buyer expecting research-level amounts of ashwagandha, maca or L-arginine will not find them in this formula.

“We would rather a buyer understand exactly what each gummy contains and decide it is not right for them than buy it expecting something the label does not support,” Kevin Show said. “That is the standard we would want applied to any supplement, including ours.”

Ingredient research is a reason to look closely at a formula, but it does not replace testing of the formula itself. HoneyFil has not published a clinical trial of the finished gummy.

Format and Daily Use

HoneyFil is meant to be added to a balanced routine, not to replace one. The brand says it is formulated to support steady daily energy and overall men’s wellness, and recommends consistent daily use for 30 to 90 days before deciding whether it suits a person’s routine. Sleep, physical activity, diet and medical history have the largest influence on energy and general health.

Anyone with ongoing tiredness or a diagnosed health condition should see a licensed clinician rather than rely on a dietary supplement.

Quality and Manufacturing

According to the brand, HoneyFil is manufactured and packaged in the United States in a GMP-certified, FDA-registered facility. The stated shelf life is 24 months from the manufacturing date printed on each bottle, with storage recommended in a cool, dry place.

The product pages reviewed for this release do not identify the manufacturing facility or publish a certificate of analysis or third-party testing record. The company said it intends to publish batch testing information on its website.

For context, 21 CFR Part 111 requires every dietary supplement manufacturer to follow current Good Manufacturing Practice rules covering production standards, ingredient identity testing, quality control and accurate labelling, whether or not a label says so. Buyers who want manufacturing records, batch test results or an extract standardisation figure can request them from the company directly.

Who Should Check With a Doctor First

HoneyFil is intended for adults. The label directions are to take one gummy a day, ideally at the same time each day, and not to exceed that amount.

People who take nitrate medicines for a heart condition should speak with their prescriber before using HoneyFil or any product that contains Epimedium. Because the label does not state the Epimedium amount, that conversation is especially worthwhile.

People who take medicines for thyroid function, blood sugar or blood pressure, or who use sedatives or immune-suppressing medicines, should check with a doctor or pharmacist first, as ashwagandha may interact with these medicines.

Men with hormone-sensitive conditions, or those on hormone therapy, should check with a clinician before using a product that contains tongkat ali.

HoneyFil is not intended for anyone under 18. Individual experiences vary. The product is not a replacement for professional medical care.

Frequently Asked Questions About HoneyFil

What did HoneyFil publish? A dose comparison that sets the four ingredient amounts on its label beside the daily doses used in published research, along with the findings of each study as the authors reported them.

What is HoneyFil? HoneyFil is a once-daily gummy dietary supplement for adult men. It combines tongkat ali, maca, ashwagandha, L-arginine, Epimedium, and beet root and grape seed extract.

Which HoneyFil ingredient amounts are disclosed? Four of the six are printed: tongkat ali at 200 mg, maca at 100 mg, ashwagandha at 100 mg and L-arginine HCl at 50 mg. Epimedium sagittatum and the beet root and grape seed extract are listed without amounts.

Is the tongkat ali amount the same as in clinical studies? By weight, yes. The 200 mg matches the low end of the 200 to 400 mg range used in published trials. The brand does not state a standardisation figure, so it is not possible to confirm whether the active compound content matches the studied extracts.

Are the other amounts at research levels? No. Ashwagandha, maca and L-arginine are all printed at amounts well below the daily doses used in the studies cited in the comparison.

Has HoneyFil itself been clinically tested? No. The comparison covers published research on individual ingredients. No clinical trial of the finished gummy has been published.

Where is HoneyFil made? The brand states it is manufactured and packaged in the United States in a GMP-certified, FDA-registered facility. The specific facility is not named, and no certificate of analysis is currently published.

References

• Talbott SM, et al. Journal of the International Society of Sports Nutrition. 2013;10:28. doi:10.1186/1550-2783-10-28

• Leisegang K, et al. Medicina. 2022;58(8):1047. doi:10.3390/medicina58081047

• Albalawi AA. Nutrition and Health. 2025;31(4):1395-1408.

• NIH Office of Dietary Supplements. Ashwagandha: Fact Sheet for Health Professionals.

• Shin BC, et al. BMC Complementary and Alternative Medicine. 2010;10:44. doi:10.1186/1472-6882-10-44

• Bai Y, et al. American Journal of Clinical Nutrition. 2009;89(1):77-84. doi:10.3945/ajcn.2008.26544

None of these sources mentions, reviews or endorses HoneyFil.

About HoneyFil

HoneyFil is a U.S. dietary supplement brand focused on men’s wellness, based in Aurora, Colorado. Its once-daily gummy combines six botanical and nutrient ingredients, including tongkat ali, maca, ashwagandha and L-arginine, and the brand says it is manufactured in a GMP-certified, FDA-registered facility in the United States. HoneyFil prints individual milligram amounts for four of its six ingredients and publishes how those amounts compare with published research, so buyers can judge the label for themselves. More information is available on the official HoneyFil website.

Media Contact

Kevin Show
Product Lead, HoneyFil
Email: support@honeyfil.store
Phone: +1 866-541-2939
Address: 9655 E 35th Drive, Suite 100, Aurora, CO 80011, USA
Website: honeyfil.store

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Individual experiences vary. Consult a qualified health care professional before starting any dietary supplement.